- 著者
- Masaomi Nangaku Takashi Kadowaki Hiroshi Yotsuyanagi Norio Ohmagari Moritoki Egi Junichi Sasaki Tetsuya Sakamoto Yoshinori Hasegawa Takashi Ogura Shigeru Chiba Koichi Node Ryo Suzuki Yasuhiro Yamaguchi Atsuko Murashima Norihiko Ikeda Eriko Morishita Kenji Yuzawa Hiroyuki Moriuchi Satoshi Hayakawa Daisuke Nishi Atsushi Irisawa Toshiaki Miyamoto Hidetaka Suzuki Hirohito Sone Yuuji Fujino
- 出版者
- Japan Medical Association / The Japanese Associaiton of Medical Sciences
- 雑誌
- JMA Journal (ISSN:2433328X)
- 巻号頁・発行日
- vol.4, no.2, pp.148-162, 2021-04-15 (Released:2021-05-07)
- 参考文献数
- 69
- 被引用文献数
- 7
In 2020, the COVID-19 pandemic has had unprecedented impacts on various aspects of the world. Each academic society has published a guide and/or guidelines on how to cope with COVID-19 separately. As the one and only nationwide association of academic societies that represent medical science in Japan, JMSF has decided to publish the expert opinion to help patients and care providers find specifically what they want.This expert opinion is a summary of recommendations by many academic societies and will be updated when necessary. Patients that each academic society targets differ even though they suffer from the same COVID-19, and recommendations can be different in a context-dependent manner. Readers are supposed to be flexible and adjustable when they use this expert opinion.
4 0 0 0 OA Respiratory syncytial virus outbreaks are predicted after the COVID-19 pandemic in Tokyo, Japan
- 著者
- Lina Madaniyazi Xerxes Seposo Chris Fook Sheng Ng Aurelio Tobias Michiko Toizumi Hiroyuki Moriuchi Lay-Myint Yoshida Masahiro Hashizume
- 出版者
- National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
- 雑誌
- Japanese Journal of Infectious Diseases (ISSN:13446304)
- 巻号頁・発行日
- pp.JJID.2021.312, (Released:2021-08-31)
- 参考文献数
- 8
- 被引用文献数
- 12
The nonpharmaceutical interventions (NPIs) on COVID-19 can impact current and future dynamics of respiratory syncytial virus infections (RSV). In Tokyo, RSV activity declined by 97.9% (95%CI: 94.8% - 99.2%) during NPIs. A longer period of NPIs could expand susceptible populations, enhancing the potential for larger RSV outbreaks after NPIs ends.